Three-dimensional immunohistochemistry (3D-IHC) has transformed our ability to visualize the spatial arrangement of cells and molecules in intact tissues. However, traditional methods are often ...

The large-scale fabrication of mixed-halide perovskite quantum dots (QDs) with concurrently enhanced optical performances and stability remains a bottleneck for both fundamental science and industrial ...

Immunohistochemistry (IHC) is a well-established method in tissue pathology and finds critical applications in both clinical and fundamental medical science. Generally, labeled antibodies are a ...

David Mulder, from Mindpeak GmbH in Hamburg, Germany, and colleagues developed a training platform for AI-supported digital HER2 IHC assessment of breast cancer samples for pathologists.

Immunohistochemistry (IHC) examination is essential to determine the tumour subtypes, provide key prognostic factors, and develop personalized treatment plans for breast cancer. However, compared to ...

Foundation Medicine today announced that it has expanded its immunohistochemistry (IHC) test offerings to include MET IHC testing.

Complete suite of IHC testing for key biomarkers in all solid tumors, including c-MET, now available in addition to Guardant360 Tissue multiomic profiling test Guardant Health, Inc. (Nasdaq: GH ...

IRVING, Texas, May 12, 2025 /PRNewswire/ -- Caris Life Sciences ® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, performs MET Immunohistochemistry (IHC) testing ...

Table 2 Collagen IV immunohistochemistry in subepidermal autoimmune blistering diseases. This technique has the limitation that only the location of collagen IV is being marked and the presence of ...

The proven efficacy of human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate therapy for treating HER2-low breast cancers necessitates more accurate and reproducible HER2 ...

Human epidermal growth factor receptor 2 (HER2)–targeted therapy improves outcomes in HER2+ breast cancer, but efficacy in cases with discordant immunohistochemistry (IHC) and in situ hybridization ...